Documentación
Documentation
Related Documents
ListadoInicial
lisini
- IFPMA Code of Practice 2019 (Spanish)
- IFPMA Code of Practice 2019
- IFPMA Code of Practice 2019 – Introduction by Melissa Barnes, Chair of the IFPMA Ethics and Business Integrity Committee (eBIC) (Video)
- IFPMA Our Ethos
- IFPMA Code of Practice 2019 - Q&A
- Additional Questions to IFPMA Code of Practice 2019 / Practical examples
- IFPMA Code of Practice eLearning (Video)
- IFPMA Note for Guidance on Continuing Medical Education (2018)
- IFPMA - Note for Guidance on sponsorship of Events and Meetings
- IFPMA - Note for Guidance on Fees for Services (2020)
- Note for Guidance for IFPMA member companies and associations worldwide on best practice for interaction with patients, caregivers, and patient organizations
- Note for Guidance on how to foster ethical relationships with third party intermediaries in the biopharmaceutical sector
- Joint Guidance on Virtual International Medical Congresses Impacted by COVID-19
- Joint Guidance on Virtual International Medical Congresses - Webinar July 16, 2020
- Video - The value of the Ethos in the context of COVID-19
- List of Guiding Principles Promoting Good Governance in the Pharmaceutical Sector
- IFPMA Code Compliance Infographic
- Consensus Framework for Ethical Collaboration
Lisfin
lisini
- ABPI Code of Practices
- ABPI - Working with patients and patient organizations
- PMCPA - GUIDANCE ABOUT DIGITAL COMMUNICATIONS
- Criteria Applicable to Pharmaceutical Companies on Hotel Use
- General Standards Applicable in Spain to Scientific and Professional Meetings
- Hospitality Thresholds in Europe
- Spanish Code 2021 for PRINTING
lisfin
lisini
- Publicidad de medicamentos Circular Farmacia Nº 1/ 2000- COMUNIDAD AUTONOMA DE MADRID
- Guía para la publicidad de medicamentos de uso humano 2016
- Monográficos sobre publicidad de medicamentos - Generalitat de Catalunya
- Guía para la publicidad de medicamentos de uso humano dirigida al público 2019
lisfin
ListadoFin
There are additional documents in the page disclosure documents.